Patent ID: 9416166
Filing Date: 2016-08-16
CPC Classification: A61P,C07K,C12Q,G01N

Claim Text:
1. A method of treating or inhibiting a neurodegenerative disease selected from the group consisting of: Alzheimer's disease and ALS, the method comprising administering to a subject a composition comprising a reagent capable of reducing expression and/or activity of a polypeptide, wherein the sequence of said polypeptide is selected from the group consisting of a contiguous amino acid sequence being at least 90% homologous to at least 10 amino acid of: coordinates 214-274 of SEQ ID NO:2, coordinates 214-275 of SEQ ID NO:4, coordinates 214-276 of SEQ ID NO: 6, coordinates 214-300 of SEQ ID NO:8, or any combination thereof.